{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:39:47Z","timestamp":1793147987184,"version":"4.5.0"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>Sarcoidosis is a multiorgan, multisystem chronic disease of unknown etiology and unpredictable course. Health status is reduced in sarcoidosis and assessing it is a difficult multitask effort due to many faces this disease might have. Recently, a new questionnaire for assessing health status in sarcoidosis was developed by a group of authors from England\u2013King\u2019s Sarcoidosis Questionnaire (KSQ). The benefit of KSQ is the ability to develop the best care plan for the patient, as well as to differentiate the efficacy of the administered treatment.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Objective<\/jats:title>\n<jats:p>The aim of this study was to validate the KSQ in Serbian speaking population of sarcoidosis patients. The test itself is a modular, multi-organ health status measure for patients with sarcoidosis for use in clinic and the evaluation of therapies. The correlation of KSQ with different clinical course of sarcoidosis (acute vs chronic disease) and with the clinical outcome status (COS) in sarcoidosis was also investigated.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Methods<\/jats:title>\n<jats:p>A total of 159 biopsy positive sarcoidosis patients participated in this study. The average age of the participants was 49.67, majority was female (67.3%) and majority had only pulmonary form of sarcoidosis (71.7%). KSQ \u2010 new disease-specific health status instrument, was compared with 5 other already existing instruments already used and validated in sarcoidosis (Saint George Respiratory Questionnaire- SGRQ, Daily Activity List -DAL, Fatigue Assessment Scale- FAS, Medical Research Council dyspnea scale\u2013MRC, Borg Dyspnea Scale and 15D as general questionnaire.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Results<\/jats:title>\n<jats:p>KSQ has significant correlation with other quality of life questionnaires already used in sarcoidosis. Translated version of KSQ shows significant internal reliability, similar to the original KSQ. Serbian version of KSQ has significant correlation with different clinical course of sarcoidosis and with COS as well. The translated version of KSQ is reliable sarcoidosis specific instrument for assessing health status in these patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0273126","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T17:27:56Z","timestamp":1693934876000},"page":"e0273126","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["King\u2019s Sarcoidosis Questionnaire (KSQ) \u2013 Validation study in Serbian speaking population of sarcoidosis patients"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1787-1438","authenticated-orcid":true,"given":"Mihailo","family":"Stjepanovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Mihailovic-Vucinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5161-5721","authenticated-orcid":true,"given":"Branislav S.","family":"Gvozdenovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Milin-Lazovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slobodan","family":"Belic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Djurdjevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Maric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksa","family":"Golubovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"key":"pone.0273126.ref001","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders","volume":"16","author":"GW Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"pone.0273126.ref002","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1164\/rccm.201006-0865CI","article-title":"A Concise Review of Pulmonary Sarcoidosis","volume":"183","author":"RP Baughman","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"pone.0273126.ref003","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1378\/chest.125.3.997","article-title":"Health-related quality of life of persons with sarcoidosis","volume":"125","author":"CE Cox","year":"2004","journal-title":"Chest"},{"key":"pone.0273126.ref004","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1183\/09031936.00002512","article-title":"De Vries J. Sarcoidosis-associated fatigue","volume":"40","author":"M Drent","year":"2012","journal-title":"Eur Respir J"},{"key":"pone.0273126.ref005","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jpsychores.2011.09.006","article-title":"Types of fatigue in sarcoidosis patients","volume":"71","author":"WPE De Kleijn","year":"2011","journal-title":"Journal of Psychosomatic Research"},{"issue":"1","key":"pone.0273126.ref006","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12890-020-01191-x","article-title":"Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts","volume":"20","author":"HS Te","year":"2020","journal-title":"BMC Pulm Med"},{"key":"pone.0273126.ref007","first-page":"14","article-title":"Quantifying the relationship between symptoms at presentation and the prognosis of sarcoidosis","volume":"152","author":"MA Judson","journal-title":"Respir Med. 2019 Jun"},{"key":"pone.0273126.ref008","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1183\/09031936.97.10071450","article-title":"Relationship between respiratory muscle function and quality of life in sarcoidosis","volume":"10","author":"RM Wirnsberger","year":"1997","journal-title":"Eur Respir J"},{"issue":"1","key":"pone.0273126.ref009","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2007-970337","article-title":"Quality of life and health status in sarcoidosis: a review","volume":"28","author":"J De Vries","year":"2007","journal-title":"Semir Respir Crit Care Med"},{"issue":"1","key":"pone.0273126.ref010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/thoraxjnl-2012-201962","article-title":"The development and validation of the King\u2019s Sarcoidosis Questionnaire for the assessment of health status","volume":"68","author":"AS Patel","year":"2013","journal-title":"Thorax"},{"key":"pone.0273126.ref011","first-page":"75","article-title":"Defining organ involvement in sarcoidosis: the ACCESS proposed instrument","volume":"16","author":"MA Judson","year":"1999","journal-title":"ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"pone.0273126.ref012","first-page":"319","article-title":"Standardisation of spiromerty. ATS\/ERS Task Force: Standardization of Lung Function Testing","volume":"26","author":"MR Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"pone.0273126.ref013","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-94-011-2988-6_9","volume-title":"Quality of life assessment: key issues in 1990s","author":"H Sintonen","year":"1993"},{"key":"pone.0273126.ref014","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","article-title":"A self-complete measure of health status for chronic airflow limitation. The St George\u2019s respiratory questionnaire","volume":"145","author":"PW Jones","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"pone.0273126.ref015","volume-title":"The 15D-measure of health-related quality of life: I: reliability, validity and sensitivity of its health state descriptive system: working paper 41","author":"H Sintonen","year":"1994"},{"key":"pone.0273126.ref016","volume-title":"The 15D-measure of health-related quality of life II: feasibility, reliability and validity of its valuation system: working paper 42","author":"H Sintonen","year":"1994"},{"key":"pone.0273126.ref017","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1378\/chest.116.5.1175","article-title":"Assessment of Health-Related Quality of Life in Patients with Interstitial Lung Disease","volume":"116","author":"JA Chang","year":"1999","journal-title":"CHEST"},{"key":"pone.0273126.ref018","volume-title":"MRC committee on environmental and occupational health","year":"1986"},{"key":"pone.0273126.ref019","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-198105000-00001","article-title":"Advances in the measurement of functional status: construction of aggregate indexes","volume":"19","author":"AL Stewart","year":"1981","journal-title":"Med Care"},{"key":"pone.0273126.ref020","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.rmed.2008.05.001","article-title":"Differences in symptom severity and health status impairment between. patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis","volume":"102","author":"BS Gvozdenovic","year":"2008","journal-title":"Respir Med"},{"key":"pone.0273126.ref021","first-page":"56","article-title":"Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force","volume":"28","author":"RP Baughman","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"pone.0273126.ref022","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/0049124187016001004","article-title":"Practical Issues in Structural Modeling","volume":"16","author":"P. Bentler","year":"1987","journal-title":"Sociological Methods & Research"},{"key":"pone.0273126.ref023","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1164\/rccm.200211-1343OC","article-title":"The Sarcoidosis Health Questionnaire: a new measure of health-related quality of life","volume":"168","author":"CE Cox","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"pone.0273126.ref024","first-page":"75","article-title":"Validation of the King\u2019s Sarcoidosis Questionnaire (KSQ) in a Dutch sarcoidosis population","volume":"33","author":"MJ Van Manen","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"pone.0273126.ref025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12955-019-1131-z","article-title":"Translation and psychometric properties of the King\u2019s Sarcoidosis Questionnaire (KSQ) in German language","volume":"17","author":"E Farin","year":"2019","journal-title":"Health Qual Life Outcomes"},{"key":"pone.0273126.ref026","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1001\/jama.2014.13128","article-title":"Minimal clinically important difference: defining what really matters to patients","volume":"312","author":"AE McGlothlin","year":"2014","journal-title":"JAMA"},{"key":"pone.0273126.ref027","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1513\/AnnalsATS.202006-607OC","article-title":"Evaluating the minimal clinically important difference of the King\u2019s Sarcoidosis Questionnaire in a multicenter prospective study","volume":"18","author":"RP Baughman","year":"2021","journal-title":"Ann Am Thorac Soc"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0273126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T17:28:13Z","timestamp":1693934893000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0273126"}},"subtitle":[],"editor":[{"given":"Gernot","family":"Zissel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":27,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0273126","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,5]]}}}